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ABSTRACT Substitution of 29-deoxy ATP (dATP) for ATP as substrate for actomyosin results in signiﬁcant enhancement of in
vitro parameters of cardiac contraction. To determine the minimal ratio of dATP/ATP (constant total NTP) that signiﬁcantly
enhances cardiac contractility and obtain greater understanding of how dATP substitution results in contractile enhancement, we
varied dATP/ATP ratio in porcine cardiacmuscle preparations. AtmaximumCa21 (pCa 4.5), isometric force increased linearly with
dATP/ATP ratio, but at submaximal Ca21 (pCa 5.5) this relationship was nonlinear, with the nonlinearity evident at 2–20% dATP;
force increased signiﬁcantly with only 10% of substrate as dATP. The rate of tension redevelopment (kTR) increased with dATP at
all Ca21 levels. kTR increased linearly with dATP/ATP ratio at pCa 4.5 and 5.5. Unregulated actin-activated Mg-NTPase rates and
actin sliding speed linearly increased with the dATP/ATP ratio (p , 0.01 at 10% dATP). Together these data suggest cardiac
contractility is enhanced when only 10% of the contractile substrate is dATP. Our results imply that relatively small (but
supraphysiological) levels of dATP increase the number of strongly attached, force-producing actomyosin cross-bridges, resulting
in an increase in overall contractility through both thin ﬁlament activation and kinetic shortening of the actomyosin cross-bridge
cycle.
INTRODUCTION
Cardiac contractility can be enhanced by a variety of mech-
anisms, including those that directly affect actomyosin in-
teractions. One such positive inotropic effector that acts
primarily via actomyosin is replacement of ATP by 29-deoxy
ATP (dATP) as substrate for cardiac muscle contraction (1).
With both a-myosin heavy chain (a-MHC, fast isoform)
from untreated rats and b-myosin heavy chain (b-MHC,
slow isoform) frompropylthiouracil (PTU) treated rats, replace-
ment of ATP with dATP as the substrate for cardiac contrac-
tion resulted in signiﬁcant increases of contractile parameters
(1). The effects of this substrate substitution on mechanical
properties were evaluated with isometric force (Fiso), rate of
tension redevelopment (kTR), unloaded shortening velocity
(Vus) at maximum activating [Ca
21], as well as unregulated
NTP hydrolytic activity (Mg-NTPase) and in vitro motility
(IVM) actin sliding speed; all parameters were signiﬁcantly
enhanced in rat cardiac muscle, and these effects are larger
than in skeletal muscle (2–4). From these results it is evident
that dATP as substrate increases the number of strongly at-
tached, force-producing actomyosin cross-bridges. How-
ever, it is not structurally clear why the removal of one
oxygen from the ATP structure should cause a change in
myosin activity and the actomyosin force generating cycle.
Although studies have indicated that ATP and dATP have a
similar binding afﬁnity for myosin (1), it is possible that the
Km of dATP for myosin is lower than that of ATP, which
could lead to higher afﬁnity of myosin for dATP. An overall
enhancement of actomyosin kinetics with dATP may result
in a shorter cross-bridge cycle. Cardiac contractility may be
thus enhanced both by greater numbers of strong cross-
bridges and a faster cross-bridge cycle when dATP is utilized
as contractile substrate.
To understand which properties of cardiac thin ﬁlament
activation can be limiting to contraction, Regnier et al. inves-
tigated Fiso and kTR utilizing dATP as an analog of ATP for
in vitro assays with rat cardiac trabeculae (5). This study
showed that dATP as contractile substrate increased the
Ca21 sensitivity of both Fiso and kTR and increased both
force and kTR at maximum activating Ca
21. The force-kTR
relation was unaltered at lower levels of steady-state force
but was extended to higher force and kTR with dATP for both
the a- and b-MHC rat cardiac isoforms. This led to the con-
clusion that even at saturating Ca21, thin ﬁlament Ca21
activation may limit the rate of force development in rat
cardiac muscle (5). If dATP increases the number of strong
cross-bridges, cross-bridge enhancement of thin ﬁlament ac-
tivation could become prominent in cardiac contraction at
all levels of Ca21 activation (6). This mechanism is plausible
because N-ethyl-maleimide myosin subfragment 1 (NEM-
S1), a long-lived analog of a strongly bound cross-bridge in
the presence of NTP, increases kTR at submaximal Ca
21
levels that can reach or exceed the rate normally achieved at
maximumCa21 activation (7). Because Ca21 activation is lim-
iting under normal conditions as well as heart failure condi-
tions, there is a maximum increase in contractile parameters
that occurs with increasing intracellular [Ca21]. However,
the rat cardiac trabeculae studies indicate that cardiac
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contraction can be further enhanced with dATP as contractile
substrate due to the increased numbers of strong force-
producing cross-bridges that activate the thin ﬁlament above
that normally achievable at high [Ca21] (5).
In addition to thin ﬁlament activation by increased
numbers of strongly attached cross-bridges, it is possible
that the enhanced force-pCa relationship found with dATP as
contractile substrate is partially due to increased duty ratio.
The increased duty ratio may be a result of a shorter overall
cross-bridge cycle and an increased afﬁnity of dATP for my-
osin over that of ATP. This assumption is reasonably in-
ferred from the effects of dATP on rat cardiac contraction in
unregulated in vitro assays (1) without the inﬂuence of the
thin ﬁlament regulatory proteins. Microneedle assays mea-
suring steady-state force generated on individual unregulated
actin ﬁlaments interacting with a rabbit skeletal HMM
(heavy meromyosin) coated surface showed that mean force
per ﬁlament length was increased by approximately threefold
when dATP was substituted for ATP as contractile substrate
(8); an increased actomyosin duty ratio may account for this
effect.
To date, all studies utilizing dATP as substrate in vitro
have completely replaced ATP with dATP. It is therefore of
interest to know if a small increase in the dATP/ATP ratio
can signiﬁcantly enhance cardiac contractility. Increased
dATP in vivo has potential as a therapeutic intervention for
the symptoms of heart failure because its positive inotropic
action would be through a direct effect on the myoﬁlaments
(1,9). To determine the smallest dATP/ATP ratio that can
signiﬁcantly enhance in vitro cardiac contractility, we ex-
plored the effects of increasing ratios of dATP/ATP
(constant total [NTP]) on cardiac muscle contraction. We
also investigated the hypothesis that dATP affects cardiac
contraction primarily via recruitment of strong actomyosin
cross-bridges and examined the possibility that dATP in-
creases duty ratio while shortening the cross-bridge cycle.
Previous studies with dATP utilized rat cardiac muscle
preparations. We used porcine cardiac muscle as our model
because the b-MHC isoform in pigs is kinetically more like
human cardiac b-MHC isoform than that in rodents (10).
Here we test the hypothesis that a relatively small ratio of
dATP/ATP (but greater than physiological) can signiﬁcantly
enhance contractile parameters and actomyosin cross-bridge
cycling, manifested as the combination of higher numbers of
strongly attached force-producing cross-bridges, increased
NTP hydrolysis rate, increased rate of myosin head attach-
ment, and increased rate of myosin head detachment. We
predicted that these effects would substantiate previous evi-
dence that strong cross-bridge binding can signiﬁcantly in-
crease force by enhancement of activation of the thin
ﬁlament in cardiac muscle and that dATP as substrate causes
an enhancement of in vitro indicators of contractility. To test
our hypothesis we ﬁrst characterized the force-pCa relation-
ship with permeabilized porcine cardiac papillary muscle
ﬁber bundles, utilizing either 100% ATP or 100% dATP as
contractile substrate. Next, we measured steady-state force
and kTR in porcine cardiac ﬁber bundles as the ratio of dATP/
ATP was increased with a constant total NTP concentration.
To investigate effects on the cross-bridge cycle, we com-
pared unregulated actin-activated Mg-NTPase rates and un-
regulated actin sliding speeds (with IVM) as ratios of dATP/
ATP were increased (constant total [NTP]) utilizing porcine
cardiac myosin (pcMyosin).
We found that porcine cardiac Fiso was increased at pCa#
5.7 when dATP replaced ATP, and pCa50 was unchanged. At
maximum Ca21 (pCa 4.5) Fiso increased linearly with dATP/
ATP ratio, but at submaximal Ca21 (pCa 5.5) this relation-
ship was nonlinear. The increase in Fiso was highly sig-
niﬁcant when as little as 10% dATP (90% ATP) was present.
kTR increased with dATP at all levels of Ca
21 activation and
increased linearly with an increase in the dATP/ATP ratio.
Actin-activated Mg-NTPase rate as well as unregulated actin
sliding speed with pcMyosin increased linearly with dATP/
ATP ratio; actin sliding speed was signiﬁcantly increased
with only 10% dATP/ATP. Together these data suggest that
the cardiac contractility with the porcine b-MHC isoform is
increased when at least 10% of the contractile substrate is
dATP and that dATP increases the actomyosin duty ratio
while shortening the overall cross-bridge cycle. In addition,
an increase in the number of strongly attached cross-bridges
with dATP enhances activation of the thin ﬁlament for an
overall increase in contractility.
Preliminary abstracts of this work have been published
(11,12).
METHODS
Rabbit skeletal muscle actin
Male New Zealand White rabbits were handled in accordance with the
current National Institutes of Health/National Research Council Guide for
the Care and Use of Laboratory Animals. All procedures and protocols were
approved by Florida State University’s Institutional Animal Care and Use
Committee. Actin used in the motility and Mg-Mg-NTPase assays was ex-
tracted from acetone powder prepared from New Zealand White rabbit back
and leg muscles (13,14). Proteins are routinely analyzed by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE).
Porcine cardiac muscle preparations
Porcine hearts were obtained from a local abattoir within 20 min of the
animal’s death.
Skinned papillary muscle strips
For ﬁber mechanics, hearts were temporarily stored in oxygenated Ringer’s
solution (116 mM NaCl, 4.6 mM KCl, 1.16 mM KH2PO4, 25.3 mM
NaHCO3, 2.5 mM CaCl2, and 1.16 mM MgSO4) on ice for transport to the
laboratory, where the cardiac papillary muscles were immediately dissected.
Muscle strips;3–5 mm in diameter and 5 mm in length were sectioned from
the left ventricle papillary muscle, then tied to Teﬂon strips for storage. The
strips were skinned in a 1% Triton X-100 relaxing (pCa 8) solution for 24 h
at 4C. The strips were rinsed, then stored in a 50% v/v glycerol-pCa 8
solution at 20C (15). Small bundles of permeabilized muscle from these
strips were used within 1 month after dissection.
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Puriﬁed cardiac myosin
For pcMyosin used in the IVM assays and actin-activated Mg-NTPase as-
says, fresh porcine hearts were rinsed in ice cold phosphate buffer saline
(PBS) (137 mMNaCl, 2.7 mMKCl, 10 mMNa2HPO4, 1.8 mMKH2PO4) to
remove residual blood, and the atria were removed. The ventricles were
transported in cold buffer consisting of 25 mMNa2EGTA, 50 mMMOPS 3-
((N-morpholino)propanesulfonic acid), 6 mM MgCl2, 4 mM acetic acid,
5.5 mM ATP, 2 mM DTT (1,4-dithiothreitol), 50 mg/ml leupeptin, 1 mg/ml
pepstatin A, 0.2 mM phenylmethylsulfonylﬂuoride (PMSF), and Complete
Protease inhibitor cocktail (Roche Diagnostics, Mannheim, Germany), pH
6.8, maintained on ice. Ventricles were ground in a cold meat grinder, and
50–75 g of tissue was homogenized in 400 ml of buffer A. Buffer A
consisted of 0.3 M KCl, 10 mM Na4P2O7, 1 mM MgCl2, 20 mM DTT, 5
mM EGTA, 150 mM K2HPO4, 5 mg/ml leupeptin, 0.7 mg/ml pepstatin A,
0.2 mM PMSF, pH 6.8. pcMyosin was extracted from this tissue homog-
enate, ﬁltered, diluted with 20 vol cold 1 mM DTT, and allowed to precipitate
overnight at 4C. The pcMyosin precipitate was pelleted and then resuspended
in 0.3 MKCl, 10 mM imidazole, 5 mMMgCl2, 20 mMDTT, 10 mMATP, 5
mg/ml leupeptin, 0.7 mg/ml pepstatin A, pH 6.8. This resuspension was
centrifuged at 19,000 rpm (SS-34 rotor) for 30 min to remove insoluble
actin. The supernatant was diluted with 8 vol of cold 1 mM DTT and
allowed to precipitate for 3 h. The pcMyosin precipitate was pelleted and re-
suspended in 0.6 M KCl, 2 mM MgCl2, 5 mM DTT, 10 mM Tris-HCl, and
Complete Protease inhibitor cocktail, pH 7.6, then stored in 50% glycerol (v/v).
To prepare the glycerinated pcMyosin for use in most motility assays, the
glycerol stock was precipitated with a bicarbonate buffer consisting of
0.1 mM NaHCO3 and 0.1 mM EGTA, then centrifuged to form a pellet. The
pellet was resuspended in 11.4 mM imidazole-HCl, 0.67 M KCl, 2.3 mM
MgCl2, 0.04 mM NaHCO3, 0.04 mM EGTA, and concentration of
pcMyosin was determined by a modiﬁed Bradford assay (Pierce Biotech-
nology, Rockford, IL). Bicarbonate buffer with 3 mM MgCl2 was added to
this solution at 1.2 ml/mg of pcMyosin. After centrifugation to remove
any precipitated pcMyosin and actin, the concentration of the resulting
pcMyosin preparation in solution was determined. For studies where high
concentrations of pcMyosin were needed to compare motility at different
pcMyosin densities, the pellets were resuspended in 0.3 M KCl, 25 mM
imidazole, 1 mMEGTA, 4 mMMgCl2, and 10 mMDTT (16). In both cases,
prepared pcMyosin was treated with equimolar actin and 1 mM ATP and
then centrifuged to remove dead heads. Although the majority of dead heads
were removed at this step, a small proportion of dead heads remained in the
preparation due to the salt concentration necessary to keep pcMyosin in
solution.
To prepare the pcMyosin for Mg-NTPase analysis, glycerinated stock
was precipitated with a bicarbonate buffer consisting of 0.1 mM NaHCO3
and 0.1 mM EGTA and then centrifuged. The pellet was resuspended in
Mg-NTPase buffer consisting of 1 mM DTT, 5 mM MgCl2, 1 mM EGTA,
25 mM Tris (pH 7.0), and 0.3 M KCl; 0.1 M stocks of ATP and dATP were
mixed in designated ratios of dATP/ATP.
Fiber mechanics
Mounting of glycerinated porcine papillary ﬁbers
For experiments, small ﬁber bundles were separated from glycerinated
muscle strips, and the ends were wrapped in aluminum foil T-clips for
attachment to the force transducer via small wire hooks. Fiber bundles were
mounted on a motor (step time 300 ms) (Aurora Scientiﬁc, Ontario, Canada)
to control overall ﬁber length at one end, and on a capacitative-type force
transducer (fc ¼ 3.3 kHz; Aurora Scientiﬁc) at the other end. The motor and
force transducer were located on a modiﬁed stage of an inverted microscope
(17). L0 was determined and set by reducing passive tension at pCa 9 to zero
baseline before the start of each experiment. Fiber length and ﬁber diameter
(measured with an optical micrometer) were measured before the start of
each experiment. Fiber bundles were 2436 39 mm wide and 1.56 0.3 mm
long (n ¼ 15).
Experimental control, data acquisition, and data analysis
Steady-state isometric force and the kinetics of tension redevelopment (kTR)
were determined as described previously (14,18,19). kTR was obtained after
recording steady-state isometric force by applying a rapid shortening, then
restretch to original ﬁber length (14). The experimental control system em-
ployed periodic (0.2 Hz) unloading (i.e., ;15% original length (L0) ﬁber
shortening followed by restretch to L0). Force was digitized and analyzed
using custom data acquisition and control software (20). All signals were low-
pass ﬁltered (CyberAmp 380, Axon Instruments, Foster City, CA) to avoid
aliasing. Steady-state isometric force was measured with the capacitative-
type force transducer. In all experiments, ﬁbers were moved rapidly between
solutions of varying pCa and/or varying dATP/ATP concentrations. Ex-
perimental solutions were held in 100- or 200-ml anodized aluminum wells.
The bottom of each well consisted of a glass No. 1 thickness coverslip. The
temperature of the wells was set at 15C and controlled to within 1C during
individual experiments using an ATR-4 adaptable thermoregulator (Quest
Scientiﬁc, North Vancouver, BC, Canada). Reduced temperature (15C) and
length cycling were utilized to maintain integrity of ﬁber structure and
mechanical properties during prolonged activation. Measurements of total
force were obtained from the initial portion of digitized records in which the
zero-force baseline was determined by subsequent slackening of the ﬁber.
Passive force was determined in the same manner at pCa 9.0 and was
subtracted from the total force to obtain active force. Data were discarded if
maximum Ca21-activated force in control conditions decreased more than
20% of the initial control. Force redevelopment kinetics (kTR) were char-
acterized by obtaining an apparent rate constant (expressed as reciprocal
seconds) from the linear transformation of the half-time estimate (t1/2)
extrapolating from 50% to 63.2% (kTR ¼ t1 ¼ ln 0.53(t1/2)1) (4,14).
Monoexponential ﬁts to the data, obtained with the Simplex method for
nonlinear least-squares regression, gave similar results.
The relation between steady-state, active isometric force (Fiso) and pCa
was ﬁt to the Hill equation (Eq. 1) by nonlinear least-squares regression with
Sigma Plot 2002 for Windows (version 8.0; SPSS, Chicago, IL).
Fiso
F0
¼ Fmax=F0ð11 10nðpCapCa50ÞÞ; (1)
where Fmax is the maximum active force at saturating [Ca
21] for a given con-
dition, F0 is the maximum force at saturating [Ca
21] for ATP (i.e., Fmax¼ F0
for ATP), pCa50 is the pCa at which Fiso ¼ Fmax/2, and n is related to the
steepness of the Ca21 dependence around pCa50.
Solutions
Relaxing and activating solutions were prepared as described previously
(17,21) and contained 5 mM MgNTP (either ATP or dATP, or a combina-
tion of the two), 15 mM phosphocreatine, 1 mM Pi, 10 mM EGTA, 50 mM
MOPS, 1 mM Mg21, 45 mM free Na1, 100 mM free K1, 1 mM DTT, and
200–400 units/ml creatine phosphokinase. Ca21 solutions were prepared at
evenly spaced pCa values (pCa ¼ log[Ca21], where [Ca21] is in molar)
ranging from pCa 9 (relaxing) to pCa 5.0, plus pCa 4.5 (maximally acti-
vating). Intermediate pCa solutions were obtained by mixing prescribed
volumes of the evenly spaced solutions. To alter solution [Ca21], appro-
priate amounts of Ca(acetate)2 were added, taking into account desired free
[Ca21] and the binding constants of all solutions constituents for Ca21. Ionic
strength was maintained constant (180 mM) by varying Tris and acetate.
Solution pH was adjusted to 7.0 at 12C. Chemicals used in all experiments
were supplied by Sigma-Aldrich (St. Louis, MO).
Diffusion-related radial NTP gradients were calculated as described
previously (22) to estimate the magnitude of steady-state [NTP] gradients
throughout the ﬁber bundle diameter. Calculations were made based on the
radius of the largest ﬁber used for experiments (150 mm) and the con-
centration of total NTP (5 mM), NDP (;0.07 mM), and PCr (15 mM) in the
ﬁber mechanics bathing solutions. These calculations were made assuming
that CK activity was sufﬁcient to maintain steady state throughout the ﬁber
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bundle and that the Mg-NTPase rate was equivalent to that obtained in our
solution actin-activated Mg-NTPase assays for dATP, since dATP was the
faster rate. We also calculated the gradients using 23 the experimental
dATPase rate to test the hypothetical case where Mg-NTPase rate in the
intact sarcomere was larger than the measured solution Mg-NTPase rate. At
13 the dATPase rate, the ﬁnal [dATP] at the center of the ﬁber was
calculated to be ;5 mM, and the ﬁnal [dADP] was ;5 mM. At 23 the
dATPase rate, ﬁnal [dATP] was;5 mM and ﬁnal [dADP] was;14 mM. In
absolute concentrations, these calculations represent an increase in [NDP]
from1 mM to ;10 mM. Thus both the concentration of NDP throughout
even the largest diameter ﬁber bundles and particularly the correspondingly
small gradients of NTP were considered negligible in these experiments.
In vitro motility assays
Solutions and ﬂow cell preparation
IVM assays were performed to measure the sliding speed of ﬂuorescently
labeled F-actin over pcMyosin-coated surfaces. Experimental protocols, so-
lution preparation, ﬂow cell preparation, and analysis were essentially as
described previously for rabbit skeletal HMM (23), with minor alterations
for the pcMyosin preparation. Myosin concentration applied to motility ﬂow
cells was typically 0.15 mg/ml, which yielded smooth (nonerratic) motility
of the actin ﬁlaments. In a subset of experiments, the concentration of
pcMyosin was varied to alter the density of myosin on the ﬂow cell surface
(24). F-actin was ﬂuorescently labeled with rhodamine phalloidin (RhPh).
Assays were carried out at 30C, with temperature in the ﬂow cell
maintained by an objective heating element (Temperature Controller B600;
20/20 Technology, Wilmington, NC); 0.1 M stocks of ATP and dATP were
mixed in designated ratios of dATP/ATP. Immediately before the motility
assay, 2 mM NTP (ATP, dATP, or a designated ratio of the two), 16.7 mM
glucose, 100 mg/ml glucose oxidase, 18 mg/ml catalase (Worthington
Biochemical, Lakewood, NJ), 0.3% methyl cellulose, and an additional 40
mM DTT were added to actin buffer (AB), composed of 25 mM KCl, 25
mM imidazole, 4 mM MgCl2, 1 mM EGTA, 1 mM DTT, at pH 7.4 (25).
Glucose, glucose oxidase, catalase, and extra DTT were added to minimize
photobleaching of the RhPh label and photooxidative damage to the proteins
(25,26).
Fluorescence microscopy and data acquisition
RhPh-labeled F-actin motility was observed by ﬂuorescence microscopy
on a Nikon Eclipse TE2000-U microscope (Nikon USA, Melville, NY) at
1003 or 1503 magniﬁcation, imaging ﬁve to six ﬁelds from varying areas
on the ﬂow cell. Field images were recorded as 30-s video clips using a
VE1000SIT camera (Dage-MTI, Michigan City, IN) and a Sony RDR-GX7
DVD recorder. The DVD clips were processed using iMovie software as
QuickTime ﬁles on a Macintosh 2X PowerPC G4 computer with a Miglia
video interface (Miglia Technology, Enﬁeld, UK). RhPh F-actin sliding
speed distributions were analyzed by custom motion analysis software pro-
grams (designed by Thomas Asbury, P. Bryant Chase, and Nicolas Brunet,
Florida State University). Brieﬂy, individual ﬁlament speed was measured
by tracking the centroids of ﬁlaments. A mean sliding speed for all ﬁlament
paths (Vf) was calculated for each ﬂow cell after removal of paths that had a
ratio of mean 6 SD path speed .0.3; this procedure effectively omits data
from immobile ﬁlaments and ﬁlaments with erratic movement (23,26,27).
Actin-activated Mg-NTPase assays
Solutions
Actin-activated Mg-NTPase assays were performed as previously described
(28) to measure the actin-activated rate of pcMyosin MgNTP hydrolysis in
solution. Individual reactions were set up for each level of dATP/ATP in a
microcentrifuge tube. Final reactions took place in a buffer of 1 mM DTT,
5 mM MgCl2, 1 mM EGTA, 25 mM Tris (pH 7.0), and 0.05 M KCl,
and utilized 0.2 mg/ml pcMyosin, 0.25 mg/ml F-actin, and 1 mM NTP
(ATP, dATP, or a designated ratio of the two). Mg-NTPase reactions were
stopped by addition of 13.3% SDS in 0.12 M EDTA, pH 7.0 (STOP
solution), and indicator solution consisting of 0.5% ammonium molybdate
(w/v), 0.5 M H2SO4, and 5 mg/ml ferrous sulfate.
Actin-activated Mg-NTPase activity
Timing of the assay began immediately upon addition of NTP; reactions
were allowed to proceed with aliquots removed at indicated time points and
dispensed directly into tubes containing STOP solution to terminate the re-
action. Once all time points for each dATP/ATP ratio level were collected,
indicator solution was added to each tube, and the tubes were incubated at
37C for 15 min to allow color development. Absorbance was determined on
a Beckman Coulter DU640 spectrophotometer (Beckman Coulter, Fullerton,
CA) at 550 nm and converted to Pi concentration. Rate was based on the
slope of the line obtained when Pi production was plotted against time, di-
vided by the concentration of pcMyosin used in the assay. Mg-NTPase rate
was determined for each dATP/ATP ratio level and plotted using linear
regression with Excel (version 2000; Microsoft, Redmond, WA) or Sigma
Plot 2002 for Windows (version 8.0; SPSS). Controls used in the assay in-
cluded a negative NTP control with no NTP added, a negative ATP control
with 100% ATP but no pcMyosin added, and a negative dATP control with
100% dATP but no pcMyosin added.
Data analysis and statistical analyses
All linear relationships (see Figs. 2–7) represent linear least-squares re-
gressions. Statistical analyses for all experiments, including linear and non-
linear least-squares regression, were performed using Excel (version 2000;
Microsoft) or Sigma Plot 2002 for Windows (version 8.0; SPSS). Where
signiﬁcance was applicable to ﬁber mechanics and IVM, the Student’s t-test
was used to compare means.
RESULTS
Steady-state force
Fig. 1 summarizes steady-state isometric Ca21-activated force
in chemically permeabilized porcine cardiac papillary ﬁber
bundles at either 5 mM ATP (solid symbols) or 5 mM dATP
(open symbols). Passive force (pCa 9) was subtracted, and
the resulting active force (Fiso) at each pCa was normalized
to F0 (pCa 4.5) for ATP for each individual ﬁber bundle. Fiso
increased with dATP substituted for ATP at pCa levels
between pCa 5.7 and pCa 4.5. The average maximal Ca21-
activated force (Fmax) at pCa 4.5 was 7.8 mN/mm
2. In this
series of experiments, the data points show that Fmax (pCa
4.5) was increased by;9% with dATP as compared to ATP;
at pCa 5.5, Fiso was increased by ;20% with dATP. Hill
regression ﬁts to these data indicate;20% increase in Fiso at
both pCa 4.5 and 5.5. Increases in Fiso found between ATP
and dATP were smaller than those found in b-MHC rat
(;39%, pCa 4.5;;160%, pCa 5.5) (5). Force-pCa data were
ﬁt with the Hill equation (Eq. 1) to obtain estimates of pCa50
and nH. We found no difference in pCa50 between ATP
and dATP data in the porcine preparation, but we found over-
all higher Ca21 sensitivity of force in the porcine prepara-
tion (Fig. 1; ATP, pCa50 ¼ 5.9 6 0.02) as compared to
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previously published data from rat (ATP, pCa50 ¼ 5.43 6
0.01) (5). There was no difference in nH between ATP and
dATP in the porcine preparation (Fig. 1).
In a separate set of experiments, we examined the steady-
state force of the porcine cardiac papillary ﬁber bundles with
increasing ratios of dATP/ATP at constant total NTP ¼ 5
mM. Normalized data for pCa 4.5 and 5.5 are summarized in
Fig. 2. The level of isometric force generally increased as the
ratio of dATP/ATP was increased at both pCa levels. For this
data set, overall force increases were ;8% for pCa 4.5, and
;35% for pCa 5.5 with 100% dATP compared to ATP. At
submaximal Ca21 activation (pCa 5.5), there was a highly sig-
niﬁcant increase in the Fiso at 10% dATP (p , 0.01), where
force was increased by ;20%.
At pCa 4.5, the relationship between normalized force and
dATP/ATP was essentially linear (Fig. 2). Interestingly, at
pCa 5.5, the relationship was clearly nonlinear (Fig. 2). At
dATP/ATP ratios between 2 and 20% the slope was higher
than between 20 and 100%, indicating high increases in
steady-state force as the proportion of dATP was increased
by a small amount and smaller, linear increases in force as
the proportion of dATP was increased further. The nonlinear
relation between Fiso at pCa 5.5 and dATP/ATP was ﬁt by
nonlinear regression to a modiﬁed mixed alternative sub-
strates equation (29), (alternative substrates were ATP or
dATP).
Fiso
F0
¼
fA
½ATP
KmATP
1 fdA
½dATP
z3KmATP
11
½ATP
KmATP
1
½dATP
z3KmATP
; (2)
where Fiso/F0 is the normalized force at any given ratio of
[dATP]/[ATP], fA and fdA represent force for 100% ATP or
100% dATP at each Ca21 level, Km is the Km of ATP for
myosin ﬁxed at 2.3 mM (30), and z represents the factor by
which the Km of dATP differs from that of ATP (KmdATP ¼
z 3 KmATP). Regression parameter z ¼ 0.23 6 0.09 (Eq. 2)
at pCa 5.5, implying that the apparent afﬁnity of dATP
for pcMyosin is approximately fourfold higher than that of
ATP, although this may not be the only mechanistic ex-
planation for the nonlinearity.
Rate of force redevelopment (kTR)
The kinetics of tension redevelopment (kTR) is an indicator of
the kinetics of strong cross-bridge attachment and detach-
ment (31) and varies with Ca21 concentration (18,32–34).
Attachment/detachment kinetics determine actomyosin duty
ratio, which in turn is a primary determinant of the number of
strongly bound cross-bridges and therefore total isometric
force. A change in the number of strong cross-bridges via
altered duty ratio could further alter the number of strong
cross-bridges via an effect on cooperative activation of the
thin ﬁlament (6). Fig. 3 summarizes the Ca21 dependence of
kTR in porcine cardiac papillary muscle with either 100%
ATP or dATP as substrate. For each ﬁber, kTR values were
normalized to that obtained with ATP at pCa 4.5. At each
level of Ca21 activation, dATP increased the rate of tension
redevelopment over that achieved with ATP. These data
differ somewhat from previous rat trabeculae data, where
dATP did not affect kTR at the lowest levels of Ca
21 ac-
tivation (5). Fig. 3 also shows that with either ATP or dATP
there was little variation of kTR with [Ca
21]. This contrasts
with kTR effects seen in faster muscle types (4,5). When
normalized kTR was plotted against normalized steady-state
FIGURE 2 The relationship between isometric force and dATP/ATP
ratio. Isometric force increases linearly with dATP/ATP ratio at pCa 4.5
(open squares) and nonlinearly at pCa 5.5 (solid diamonds). Active force
was normalized to Fmax for ATP (n¼ 5–7). Lines are the linear least-squares
regression (pCa 4.5) or nonlinear least-squares regression ﬁt to Eq. 2 (pCa
5.5). Regression analysis suggests approximately fourfold higher afﬁnity of
dATP for cardiac myosin than ATP at pCa 5.5 (Eq. 2). (**p , 0.01 at 10%
dATP).
FIGURE 1 Force-pCa curves of skinned porcine papillary muscle utiliz-
ing 100% ATP (solid circles) or 100% dATP (open triangles) as the
contractile substrate. Active force was normalized to Fmax (pCa 4.5) for ATP
in the same ﬁber bundle (n¼ 7). Lines are nonlinear least-squares regression
ﬁts to the Hill equation (Eq. 1). There were no differences in parameter
estimates of pCa50 or nH between ATP versus dATP.
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isometric force measured before the release-restretch ma-
neuver (Fig. 4), we found that kTR was faster with dATP at all
force levels. In a separate set of experiments, we determined
kTR as the ratio of dATP/ATP was varied from 100% ATP to
100% dATP. Fig. 5 shows that at both pCa 4.5 (maximum
Ca21 activation) and pCa 5.5, there was a linear increase in
kTR as the dATP/ATP ratio was increased.
Actin-activated Mg-NTPase
We utilized an actin-activated Mg-NTPase assay to inves-
tigate the differences in the rates of nucleotide hydrolysis for
varying ratios of dATP/ATP under unloaded conditions with
pcMyosin. Fig. 6, A and B, shows the data obtained from one
representative experiment, and similar results were achieved
in three independent experiments. We found a linear relation-
ship between the rate of NTP hydrolysis and increasing ratio
of dATP/ATP, where hydrolysis increased as much as 27%
when dATP was completely substituted for ATP as substrate
in the assay.
In vitro motility
We utilized the unregulated IVM to examine unloaded
ﬁlament sliding and, as with the Mg-NTPase assays, inves-
tigate cross-bridge cycling without the effects of internal
loads that are present in ﬁber bundle preparations. This assay
measures the sliding speed of RhPh F-actin (Vf) as it interacts
with pcMyosin that is bound to the nitrocellulose-coated
surface of a coverslip (Methods) and gives insight into the
kinetics of the release step in the actomyosin cross-bridge
cycle. The data points presented in Fig. 7 show that Vf in-
creased by ;47% when ATP was replaced with dATP.
There was an overall linear increase in Vf as the dATP/ATP
ratio was increased. We found a highly signiﬁcant increase in
Vf at 10% dATP/ATP, corresponding with the ratio at which
signiﬁcance was found in our steady-state force data.
To determine if the quality of the motility observed with
the IVM assay could provide some directly observable in-
sight into the effect of dATP cross-bridges on actomyosin
interaction, ﬂow cells with varying pcMyosin densities
(Methods) were examined using either ATP or dATP in the
motility assay. Fig. 8 shows that the ﬁlaments at low
pcMyosin densities (,0.075 mg/ml) were very long and as
indicated in the 30-s ﬁlament position tracking, were pri-
marily immobile for both ATP and dATP. When dATP was
utilized as substrate, optimal ﬁlament sliding was achieved at
a lower pcMyosin density than with ATP. At the midrange,
optimal motility densities (between 0.075 and 0.15 mg/ml)
there was a highly signiﬁcant increase in Vf with dATP over
FIGURE 3 Faster kinetics of tension redevelopment (kTR) with 100%
dATP (open triangles) over 100% ATP (solid circles) at all levels of Ca21
activation (n ¼ 7). kTR was normalized to that at pCa 4.5 with ATP (0.346
0.009 s1). Although there was little variation of kTR with calcium con-
centration for either dATP or ATP, kTR was faster with dATP for all levels of
Ca21 activation.
FIGURE 4 The relationship between steady-state force and kTR with ATP
(solid circles) or dATP (open triangles). The data from Figs. 1 and 3 were
binned by pCa. kTR and force were normalized to that at pCa 4.5 with ATP
(open diamond). Lines represent linear least-squares regressions on the data.
kTR was higher with dATP at all levels of Ca
21 activation.
FIGURE 5 Linear relationship between kTR and dATP/ATP ratio at both
pCa 4.5 (open squares) and pCa 5.5 (solid diamonds). Lines represent linear
least-squares regressions on the data. kTR was normalized to that at pCa 4.5
with ATP (n ¼ 5–7).
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that with ATP (data not shown); ﬁlaments were of moderate
length, and most of the ﬁlaments were uniformly motile over
the 30-s time frame (Fig. 8). Motility at high densities
(.0.15 mg/ml) was qualitatively quite different; ﬁlaments
were sheared apart and measured actin sliding speed de-
creased with increase in pcMyosin density. Many ﬁlaments
were immobile, whereas those that did move had very short
ﬁlament paths over the 30-s time frame (Fig. 8). This drop-
off in motility quality quickly declined at 0.2 mg/ml with
dATP in contrast to ATP, where optimal motility could still
be maintained at 0.2 mg/ml pcMyosin density. Presumably
with an increase in the overall number of myosin heads on
the surface, there was a corresponding increase in the number
of ‘‘dead heads’’ that can hold ﬁlaments immobile. Because
more cross-bridges form at a faster on rate with dATP as
substrate at a given myosin density, there is a shearing effect,
resulting in an increase in the breakage of actin ﬁlaments at a
lower pcMyosin density (above optimal) with dATP than
ATP and an overall decrease in quality of motility. These
qualitative observations are consistent with dATP causing
increased numbers of strongly bound actomyosin cross-
bridges.
DISCUSSION
Replacement of ATP by dATP as contractile substrate for rat
cardiac muscle may cause an increase in the number of
strongly attached cross-bridges, which in turn activates the
cardiac thin ﬁlament to a level over that achievable with ATP
and saturating Ca21 (1,5). On that basis, porcine cardiac
muscle was used to determine if a low dATP/ATP ratio could
signiﬁcantly enhance experimental indicators of contraction
in vitro and also to increase our understanding of the mech-
anism by which dATP has a direct effect on the actomyosin
duty cycle during contraction. Porcine cardiac muscle was
examined because it contains a b-MHC isoform that is
kinetically similar to human (10). The two major ﬁndings of
our study are as follows: i), there is a signiﬁcant enhance-
ment of in vitro contractile parameters when only 10% of the
total ATP substrate available to pcMyosin is substituted with
dATP (Figs. 2 and 7); and ii), involvement of dATP as sub-
strate for the actomyosin cycle causes faster cycling and a
higher duty ratio, increased activation of the thin ﬁlament at
high Ca21, and overall enhanced contractility primarily via
increased numbers of strong, force-producing cross-bridges.
Partial replacement of ATP with dATP
We ﬁnd a signiﬁcant enhancement of several parameters of
cardiac contraction when only 10% of ATP available for
FIGURE 6 Data from representative assays of unregulated actin-activated
Mg-NTPase activity of pcMyosin. (A) Linear time course of Pi release for
ATP hydrolysis (100% ATP; solid circles) or dATP hydrolysis (100%
dATP; open triangles). Conditions were as described in Methods. (B) Linear
dependence of NTP hydrolysis rate on dATP/ATP ratio. Each point is
derived from the slope of a time course of Pi production as shown in panel A
(values from A correspond to the highest and lowest values on the abscissa).
Lines represent linear least-squares regressions on the data.
FIGURE 7 Linear dependence of unregulated actin sliding speed in the
IVM assay on dATP/ATP ratio. Conditions for motility assays with
pcMyosin were as described in Methods. Each point is the mean 6 SE of
speed from$150 ﬁlament paths per ﬂow cell measured in 3–8 ﬂow cells per
level (**p , 0.01 at 10% dATP). Line represents linear least-squares
regressions on the data.
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actomyosin interaction is replaced with dATP (Figs. 2 and
7). To determine if substitution of a small percentage of
ATP with dATP could achieve a signiﬁcant enhancement of
steady-state force in porcine cardiac papillary muscle, we
tested Fiso at pCa 4.5 and 5.5 with increasing ratios of dATP/
ATP (constant total NTP). The ;20% increase in force
found at pCa 5.5 with 10% dATP (90% ATP) was highly
signiﬁcant (p, 0.01, Student’s t-test). Similarly, actomyosin
interactions under unloaded conditions were examined using
the unregulated IVM assay as the ratio of dATP/ATP (con-
stant total NTP) was increased in the motility buffer. A 10%
dATP/ATP ratio resulted in a 10% increase in actin sliding
speed (Fig. 7), which was also highly signiﬁcant. Actin-
activated Mg-NTPase results followed this same general
trend (Fig. 6 B), although a signiﬁcant increase from 0% to
10% dATP/ATP could not be determined from the three data
sets obtained. We therefore conclude that if only 10% of the
ATP available to cardiac myosin was converted to dATP,
there would be a functionally signiﬁcant enhancement of
overall cardiac contractility.
With our in vitro assays, partial replacement of ATP with
dATP resulted in a linear relationship between each param-
eter measured and dATP/ATP ratio. This linear relationship
occurred almost independently of what type of measurement
was made—whether regulated or unregulated conditions,
isometric or unloaded conditions, or dynamic (kinetic) con-
ditions. Fmax (Fig. 2, pCa 4.5) increases linearly under reg-
ulated, isometric conditions. In Fig. 5, the same linear
relationship is found for kTR at both pCa 4.5 and 5.5 under
regulated and pseudoisometric conditions. The unregulated,
unloaded kinetic measurements of actin-activatedMg-NTPase
and actin ﬁlament sliding speed (Figs. 6 B and 7) with in-
creasing replacement of ATP with dATP increased the mea-
sured parameters linearly. Explanation of these observations,
along with the pCa50 and nH derived from the force-pCa data
(Fig. 1), does not require additional thin ﬁlament activation
when dATP is utilized as contractile substrate instead of
ATP. The porcine data differ from the rat data where dATP
increased Ca21 sensitivity of force, although in both cases
there was no signiﬁcant effect on nH (5).
Although most of our data suggest no increased activation
of the thin ﬁlament when dATP is contractile substrate, the
nonlinear relationship between force and dATP/ATP ratio at
pCa 5.5 (Fig. 2) may indicate otherwise. Together with the
force-pCa data (Fig. 1), this nonlinearity may be explained as
enhanced activation of the thin ﬁlament proteins, but only at
high calcium levels (pCa # 5.7). At these calcium levels,
the cooperativity of increased numbers of cross-bridges may
cause enhanced activation of the thin ﬁlament, resulting in a
steep, nonlinear relationship at the lower dATP/ATP ratios
FIGURE 8 Representative data from motility assays at different surface densities of pcMyosin. Single video frames (A–C) and centroid analysis (D–F) were
from assays conducted after applying (A, D) 0.02 mg/ml pcMyosin, (B, E) 0.15 mg/ml pcMyosin, or (C, F) 0.3 mg/ml pcMyosin. Panels D–F represent the
superposition of centroids of all actin ﬁlaments over a 30-s time period that includes the frames shown in panels A–C. Little progressive motility is indicated at
low (D) and high (F) densities by very small changes in centroid position over time. Progressive motility is indicated at optimal density (E) by continuous lines
(superimposed time series). Very short ﬁlaments are evidence for shearing of actin ﬁlaments at high pcMyosin densities (C).
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between 2 and 20%. At some point, enhanced thin ﬁlament
activation reaches a maximum, so that as the number of
strongly attached cross-bridges increases with increasing
dATP/ATP ratio, the thin ﬁlament activation enhancement
that can be achieved does not dominate in force generation.
At this point the increasing number of strongly attached
cross-bridges becomes dominant in force generation, thus the
curve reﬂects a linear increase between 20 and 100% dATP
(Fig. 2). Although we consider this to be the most likely
explanation for the observed nonlinearity, there is another
factor that may contribute to the overall effect. The mixed
alternative substrate equation used to analyze this data (Eq.
2) allows for the Km of ATP for pcMyosin to be ﬁxed at the
value measured in rabbit skeletal muscle (30) and the Km of
dATP for pcMyosin to vary. Using this model, our results
were consistent with the Km of dATP for pcMyosin being
lower than that of ATP by approximately fourfold (Results).
If this interpretation is correct, then higher afﬁnity for dATP
could also contribute to faster cycling with an increase in the
detachment rate as dATP binds pcMyosin. In either case, an
increase in the number of cross-bridges would contribute to
an increase in force.
Effects of dATP on actomyosin kinetics
In addition to increased thin ﬁlament activation, increased iso-
metric force could result from increased actomyosin duty
ratio (the steady-state fraction of actomyosin cross-bridges
that turn over in the force generating state). The duty ratio
has been deﬁned (31) as aFs where
aFs ¼
fapp
fapp1 gapp
: (3)
fapp is the transition from nonforce generating states to
force generating states and is representative of the attach-
ment phase of the cross-bridge cycle, and gapp is the tran-
sition from force generating states to nonforce generating
states and is representative of the detachment phase of the
cycle. gapp may represent g1 for isometric conditions or g2
(g2 . g1) for unloaded conditions (35). We found that Fiso
was increased with dATP substituted for ATP at pCa levels
between 5.7 and 4.5 with porcine cardiac muscle (Fig. 1) and
is indicative of an increase in aFs. This is in agreement with
observations in rat cardiac muscle (5), but only at pCa# 5.7.
At low Ca21 levels (pCa $ 6) there was no detectable in-
crease in force for the pig preparation, presumably due to
species differences in Tn and Tm isoforms. If isometric force
as reﬂected by the duty ratio is increased (Eq. 3), then either
f must increase and/or g1 must decrease; alternatively, if g1
increases, then a proportionally greater increase in f must
also occur to obtain an increase in the duty ratio.
The unloaded kinetics of actomyosin cross-bridge detach-
ment with dATP as contractile substrate was examined with
unregulated actin sliding speed and unregulated actin-activated
Mg-NTPase. An increased sliding speed with dATP indi-
cates an increase in g2. Our results (Figs. 7 and 8) support an
increase in actual numbers of interacting cross-bridges when
dATP is utilized as substrate in the actomyosin cross-bridge
cycle. The ;47% increase in sliding speed when dATP
completely replaces ATP as substrate indicates an increase in
the detachment rate of the actomyosin duty cycle, contrib-
uting to overall shortening of the cycle (Fig. 9). Likewise, the
increased Mg-NTPase rate found with dATP as substrate
(Fig. 6) is consistent with an increase in g2. Because the rate-
limiting step of NTP hydrolysis occurs when myosin is
detached from actin, an increase in the Mg-NTPase rate
results in an overall decrease in total cycling time. The Mg-
NTPase results can most simply be interpreted as an increase
in g2, but there is an alternative explanation that cannot be
ruled out. The methodology employed to measure the actin-
activated Mg-NTPase rate directly measured the Pi release
rate; therefore an increase in Mg-NTPase rate with dATP
could also reﬂect increased numbers of cycling cross-
bridges. This would mean that the afﬁnity of actin for myo-
sin increases when dATP is involved in hydrolysis. Previous
work compared the Mg-NTPase rate with increasing
concentration of F-actin, utilizing either dATP or ATP as
substrate for hydrolysis (1). The data indicated a 53% in-
crease in Vmax when dATP was utilized rather than ATP and
a slight decrease in the Km of myosin for actin with dATP as
substrate. This suggests that at least some of the increased
Mg-NTPase rate with dATP utilized as substrate for pcMyosin
(Fig. 6) could be due to an increased number of cycling
cross-bridges, but much of the rate increase is due to a
decrease in actomyosin cycle time (Fig. 9).
With porcine cardiac papillary muscle, we found that kTR
was increased with dATP over ATP at all levels of Ca21
activation (Fig. 3). Previous rat data indicated that dATP
increased kTR only at higher levels of Ca
21 activation (5).
The difference in our results can most likely be attributed to
differences in the species isoforms of thin ﬁlament regulatory
proteins. We ﬁnd an increase in kTR at all levels of Ca
21-
activated force generation, and high kTR rates correspond
FIGURE 9 Comparison of the actomyosin cycle in cardiac contraction for
ATP (left) versus dATP (right). The entire actomyosin cross-bridge cycle is
shorter with dATP due to an increase in the attachment and detachment rates,
as well as overall faster NTP hydrolysis rate during the detached phase (Det).
The percentage of the total attached time (Att) during the cycle increases,
resulting in a higher isometric duty ratio for dATP than ATP.
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with forces that are above that achievable with ATP at Fmax
(Fig. 4). This result is in agreement with previous rat data (5)
and provides additional evidence that dATP-induced binding
of higher numbers of strong cross-bridges results in higher
force due to an enhancement of thin ﬁlament activation
beyond ATP maximum calcium activation. kTR is deﬁned
as kTR ¼ f 1 g1 (32) and thus reﬂects both attachment and
detachment rates. An elevation of kTR at all levels of Ca
21-
activated force (Fig. 4) indicates that g1 is faster with dATP
than ATP (4,33). This is in agreement with the observed in-
crease in g2 (Figs. 6 and 7). The overall increase in kTR
indicates that the rate of strong cross-bridge detachment and
attachment are both enhanced when dATP is utilized as con-
tractile substrate; both rates contribute to the overall short-
ening of the entire actomyosin cycle and an increased aFs for
dATP over ATP (Fig. 9).
Mechanisms of dATP’s effect on contractility
Our data and others’ data (1–3,5) suggest that part of dATP’s
effect on contractility is due to increased number of cross-
bridges when dATP is utilized as substrate for actomyosin
kinetics rather than ATP. Fig. 4 indicates that dATP pro-
motes both higher force and kTR above that achievable with
ATP at maximum Ca21 activation. This has been described
by Regnier et al. with rat trabeculae as enhanced thin ﬁla-
ment activation via higher numbers of bound cross-bridges
with dATP (5). Our kinetic data, however, add some addi-
tional insight into the mechanisms of dATP’s contractile en-
hancement. Our data indicate a higher afﬁnity of pcMyosin
for dATP than for ATP that was observable with partial
replacement of ATP with dATP at pCa 5.5 (Fig. 2). Faster
kTR with increased isometric force indicates a faster attach-
ment rate as myosin and actin interact to enter into the
attached, force-producing phase. Our IVM, Mg-NTPase, and
kTR data indicate a faster detachment rate of myosin from
actin when dATP is substrate. The combination of a faster at-
tachment rate (f) as well as a faster detachment rate (g) results
in a higher duty ratio if a proportionally greater increase in
f occurs. In addition, the detached phase is shortened, as
evidenced by the faster Mg-NTPase. We infer that the actual
amount of time that cross-bridges remain in the attached
phase with dATP may be somewhat shorter than that for
ATP, there is a greater shortening of the overall actomyosin
cycle and thus the isometric duty ratio is actually higher with
dATP than with ATP (Fig. 9). This higher duty ratio is re-
ﬂected in the signiﬁcant increase of isometric force that is
achieved with dATP as substrate.
Although the normal physiological ratio of dATP/ATP
is 1 (36), our ﬁnding that ;10% dATP/ATP can sig-
niﬁcantly increase many aspects of cardiac contractility in
vitro has potential implications for modulation of cardiac
function. These increases are caused by an increased number
of strongly attached, force-producing cross-bridges that fur-
ther activate the thin ﬁlament and result in a shorter
actomyosin cross-bridge cycle with a higher duty ratio
when dATP is used as contractile substrate rather than ATP.
The direct effect that dATP has on actomyosin interaction
and cardiac contractility makes exploration of methods for
increasing intracellular cardiac dATP/ATP ratios attractive.
If feasible, dATP may have possibilities as a candidate for
positive inotropic therapy for the symptoms of heart failure.
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